首页> 外文期刊>Neurology India >In vitro differentiation of neural cells from human adipose tissue derived stromal cells
【24h】

In vitro differentiation of neural cells from human adipose tissue derived stromal cells

机译:神经细胞与人脂肪组织来源的基质细胞的体外分化

获取原文
           

摘要

Background: Stem cells, including neural stem cells (NSCs), are endowed with self-renewal capability and hence hold great opportunity for the institution of replacement/protective therapy. We propose a method for in vitro generation of stromal cells from human adipose tissue and their differentiation into neural cells. Materials and Methods: Ten grams of donor adipose tissue was surgically resected from the abdominal wall of the human donor after the participants' informed consents. The resected adipose tissue was minced and incubated for 1 hour in the presence of an enzyme (collagenase-type I) at 370C followed by its centrifugation. After centrifugation, the supernatant and pellets were separated and cultured in a medium for proliferation at 370C with 5% CO2 for 9-10 days in separate tissue culture dishes for generation of mesenchymal stromal cells (MSC). At the end of the culture, MSC were harvested and analyzed. The harvested MSC were subjected for further culture for their differentiation into neural cells for 5-7 days using differentiation medium mainly comprising of neurobasal medium. At the end of the procedure, culture cells were isolated and studied for expression of transcriptional factor proteins: orthodenticle homolog-2 (OTX-2), beta-III-tubulin (β3-Tubulin), glial-fibrillary acid protein (GFAP) and synaptophysin-β2. Results: In total, 50 neural cells-lines were generated. In vitro generated MSC differentiated neural cells' mean quantum was 5.4 ± 6.9 ml with the mean cell count being, 5.27 ± 2.65 × 103/μl. All of them showed the presence of OTX-2, β3-Tubulin, GFAP, synaptophysin-β2. Conclusion: Neural cells can be differentiated in vitro from MSC safely and effectively. In vitro generated neural cells represent a potential therapy for recovery from spinal cord injuries and neurodegenerative disease.
机译:背景:干细胞,包括神经干细胞(NSC),具有自我更新的能力,因此为替代/保护性疗法的建立提供了巨大的机会。我们提出了一种从人脂肪组织中体外培养基质细胞并将其分化为神经细胞的方法。材料和方法:在参与者知情同意后,从人类供体的腹壁手术切除十克供体脂肪组织。将切下的脂肪组织切碎,并在酶(I型胶原酶)存在下于37°sup0°C孵育1小时,然后离心。离心后,分离上清液和沉淀,并在单独的组织培养皿中于37°sup> 0 C和5%CO2的培养基中培养9-10天,以生成间充质基质细胞(MSC) 。培养结束时,收获MSC并进行分析。使用主要由神经基础培养基组成的分化培养基,将收获的MSC进行进一步培养以分化成神经细胞5-7天。在该过程结束时,分离培养细胞并研究转录因子蛋白的表达:直齿同源蛋白2(OTX-2),β-III-微管蛋白(β3-Tubulin),神经胶质原纤维酸性蛋白(GFAP)和突触素β2。结果:总共产生了50个神经细胞系。体外产生的MSC分化神经细胞的平均量子量为5.4±6.9 ml,平均细胞数为5.27±2.65×10 3 / μl。它们均显示了OTX-2,β3-微管蛋白,GFAP,突触素-β2的存在。结论:可以安全,有效地从MSC中体外分化出神经细胞。体外产生的神经细胞代表从脊髓损伤和神经退行性疾病中恢复的潜在疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号